Yan Han

Prof. Yan Han

Department of Plastic and Reconstructive Surgery, the First Medical Centre, Chinese PLA General Hospital
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
YHYudi Han
Yudi Han
JRJing Ren
Jing Ren
YBYun Bai
Yun Bai
XPXuetao Pei
Xuetao Pei
YHYan Han
Yan Han

1 June 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YBYun Bai
Yun Bai
YHYu-Di Han
Yu-Di Han
XYXin-Long Yan
Xin-Long Yan
JRJing Ren
Jing Ren
QZQuan Zeng
Quan Zeng
YHYan Han
Yan Han

1 February 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YHYu-Di Han
Yu-Di Han
YBYun Bai
Yun Bai
XYXin-Long Yan
Xin-Long Yan
JRJing Ren
Jing Ren
QZQuan Zeng
Quan Zeng
YHYan Han
Yan Han

6 September 2024 in ACS Nano
Verified
Journal Article
Open access
WYWen-De Yao
Wen-De Yao
Junnian ZhouJunnian Zhou
Junnian Zhou
CTChao Tang
Chao Tang
JZJu-Lei Zhang
Ju-Lei Zhang
ZCZhao-Yang Chen
Zhao-Yang Chen
WYWen Yue
Wen Yue
Rescuing or compensating mitochondrial function represents a promising therapeutic avenue for radiation-induced chronic wounds. Adult stem cell efficacies are primarily dependent on the paracrine secretion of mitochondria-containing extracellular vesicles (EVs). However, effective therapeutic strategies addressing the quantity of mitochondria and mitochondria-delivery system are lacking. Thus, in this study, we aimed to design an effective hydrogel microneedle patch (MNP) loaded with stem cell-derived mitochondria-rich EVs to gradually release and deliver mitochondria into the wound tissues and boost wound healing. We, first, used metformin to enhance mitochondrial biogenesis and thereby increasing the secretion of mitochondria-containing EVs (termed "Met-EVs") in adipose-derived stem cells. To verify the therapeutic effects of Met-EVs, we established an in vitro and an in vivo model of X-ray-induced mitochondrial dysfunction. The Met-EVs ameliorated the mitochondrial dysfunction by rescuing mitochondrial membrane potential, increasing adenosine 5'-triphosphate levels, and decreasing reactive oxygen species production by transferring active mitochondria. To sustain the release of EVs into damaged tissues, we constructed a Met-EVs@Decellularized Adipose Matrix (DAM)/Hyaluronic Acid Methacrylic Acid (HAMA)-MNP. Met-EVs@DAM/HAMA-MNP can load and gradually release Met-EVs and their contained mitochondria into wound tissues to alleviate mitochondrial dysfunction. Moreover, we found Met-EVs@DAM/HAMA-MNP can markedly promote macrophage polarization toward the M2 subtype with anti-inflammatory and regenerative functions, which can, in turn, enhance the healing process in mice with skin wounds combined radiation injuries. Collectively, we successfully fabricated a delivery system for EVs, Met-EVs@DAM/HAMA-MNP, to effectively deliver stem cell-derived mitochondria-rich EVs. The effectiveness of this system has been demonstrated, holding great potential for chronic wound treatments in clinic.

6 August 2021 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
ZYZheng Yang
Zheng Yang
YYYang Yang
Yang Yang
YXYichi Xu
Yichi Xu
WJWeiqian Jiang
Weiqian Jiang
YSYan Shao
Yan Shao
YHYan Han
Yan Han
Background: Efficient and stable delivery of neurotrophic factors (NTFs) is crucial to provide suitable microenvironment for peripheral nerve regeneration. Neurotrophin-3 (NT-3) is an important NTF during peripheral nerve regeneration which is scarce in the first few weeks of nerve defect. Exosomes are nanovesicles and have been served as promising candidate for biocarrier. In this work, NT-3 mRNA was encapsulated in adipose-derived stem cell (ADSC)-derived exosomes (ExoNT-3). These engineered exosomes were applied as NT-3 mRNA carrier and then were loaded in nerve guidance conduit (ExoNT-3-NGC) to bridge rat sciatic nerve defect. Method: NT-3 mRNA was encapsulated in exosomes by forcedly expression of NT-3 mRNA in the donor ADSCs. ExoNT-3 were co-cultured with SCs in vitro; after 24 h of culture, the efficiency of NT-3 mRNA delivery was evaluated by qPCR, western blotting and ELISA. Then, ExoNT-3 were loaded in alginate hydrogel to construct the nerve guidance conduits (ExoNT-3-NGC). ExoNT-3-NGC were implanted in vivo to reconstruct 10 mm rat sciatic nerve defect. The expression of NT-3 was measured 2 weeks after the implantation operation. The sciatic nerve functional index (SFI) was examined at 2 and 8 weeks after the operation. Moreover, the therapeutic effect of ExoNT-3-NGC was also evaluated by morphology assay, immunofluorescence staining of regenerated nerves, function evaluation of gastrocnemius muscles after 8 weeks of implantation. Results: The engineered exosomes could deliver NT-3 mRNA to the recipient cells efficiently and translated into functional protein. The constructed NGC could realize stable release of exosomes at least for 2 weeks. After NGC implantation in vivo, ExoNT-3-NGC group significantly promote nerve regeneration and improve the function recovery of gastrocnemius muscles compared with control exosomes (Exoempty-NGC) group. Conclusion: In this work, NGC was constructed to allow exosome-mediated NT-3 mRNA delivery. After ExoNT-3-NGC implantation in vivo, the level of NT-3 could restore which enhance the nerve regeneration. Our study provide a potential approach to improve nerve regeneration.

30 November 2020 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
ZCZhaoyang Chen
Zhaoyang Chen
BZBowen Zhang
Bowen Zhang
JSJun Shu
Jun Shu
HWHaiyang Wang
Haiyang Wang
YHYudi Han
Yudi Han
YHYan Han
Yan Han